APA
André-Garnier E., Ribeyrol O., Gournay J., Besse B., Coste-Burel M., Mabille-Archambeaud I., Billaud E., Biron C., Pineau S., Raffi F. & Imbert-Marcille B. (20180202). Emergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort. : Antiviral therapy.
Chicago
André-Garnier Elisabeth, Ribeyrol Olivier, Gournay Jerome, Besse Bernard, Coste-Burel Marianne, Mabille-Archambeaud Isabelle, Billaud Eric, Biron Charlotte, Pineau Solene, Raffi François and Imbert-Marcille Berthe-Marie. 20180202. Emergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort. : Antiviral therapy.
Harvard
André-Garnier E., Ribeyrol O., Gournay J., Besse B., Coste-Burel M., Mabille-Archambeaud I., Billaud E., Biron C., Pineau S., Raffi F. and Imbert-Marcille B. (20180202). Emergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort. : Antiviral therapy.
MLA
André-Garnier Elisabeth, Ribeyrol Olivier, Gournay Jerome, Besse Bernard, Coste-Burel Marianne, Mabille-Archambeaud Isabelle, Billaud Eric, Biron Charlotte, Pineau Solene, Raffi François and Imbert-Marcille Berthe-Marie. Emergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort. : Antiviral therapy. 20180202.